Get started
Work

Abstract 3877: IND-enabling characterization of DRD2/3 imipridone antagonist ONC206 for oncology

Year: 2019
Type: conference-abstract
DOI: 10.1158/1538-7445.am2019-3877
Authors: Varun V. Prabhu, Abed Rahman Kawakibi, Neel Madhukar, Mathew J. Garnett, Ultan McDermott, Cyril H. Benes, Lakshmi Anantharaman, Neil Charter, Sean Deacon, Alexander VanEngelenburg, Joseph B. Rucker, Benjamin J. Doranz, Jessica Rusert, Robert Wechsler-Reya, Olivier Elemento, Martin Stogniew, Wolfgang Oster, Sharon DeMorrow, R. Benjamin Free, David R. Sibley, Joshua E. Allen
Institutions: Oncoceutics (United States), Weill Cornell Medicine, Wellcome Sanger Institute, Massachusetts General Hospital, Integral Molecular (United States), Sanford Burnham Prebys Medical Discovery Institute, Texas A&M University, National Institutes of Health
Language: English
Open Access status: closed
OpenAlex ID: W4239714316
Cites:
Cited by: 2
Related to: 10